These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6848309)

  • 1. Potentiation of magnesium-induced neuromuscular weakness by gentamicin.
    L'Hommedieu CS; Huber PA; Rasch DK
    Crit Care Med; 1983 Jan; 11(1):55-6. PubMed ID: 6848309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of magnesium sulfate--induced neuromuscular weakness by gentamicin, tobramycin, and amikacin.
    L'Hommedieu CS; Nicholas D; Armes DA; Jones P; Nelson T; Pickering LK
    J Pediatr; 1983 Apr; 102(4):629-31. PubMed ID: 6834204
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of neuromuscular weakness in infant botulism by aminoglycosides.
    L'Hommedieu C; Stough R; Brown L; Kettrick R; Polin R
    J Pediatr; 1979 Dec; 95(6):1065-70. PubMed ID: 501488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of Clostridium botulinum toxin aminoglycoside antibiotics: clinical and laboratory observations.
    Santos JI; Swensen P; Glasgow LA
    Pediatrics; 1981 Jul; 68(1):50-4. PubMed ID: 7243509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A myasthenia-like syndrome and polyneuropathy, complications of gentamicin therapy.
    Martens EI; Ansink BJ
    Clin Neurol Neurosurg; 1979; 81(4):241-6. PubMed ID: 233206
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurobehavioral effects of neonatal hypermagnesemia.
    Rasch DK; Huber PA; Richardson CJ; L'Hommedieu CS; Nelson TE; Reddi R
    J Pediatr; 1982 Feb; 100(2):272-6. PubMed ID: 7199083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.
    Cooper AC; Commers AR; Finkelstein M; Lipnik PG; Tollefson LM; Wilcox RA; Hoff DS
    Pharmacotherapy; 2011 Jul; 31(7):649-57. PubMed ID: 21923451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of gentamicin on urinary electrolyte excretion in neonates.
    Giapros VI; Cholevas VI; Andronikou SK
    Pediatr Nephrol; 2004 Mar; 19(3):322-5. PubMed ID: 14691692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of hypocalcemia with a change in gentamicin administration in neonates.
    Jackson GL; Sendelbach DM; Stehel EK; Baum M; Manning MD; Engle WD
    Pediatr Nephrol; 2003 Jul; 18(7):653-6. PubMed ID: 12750977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of the aminoglycosidic antibiotic gentamicin of the isolated rat diaphragm. Potentiation of the neuromuscular blocking activity of gentamicin during combined application with muscle relaxant agents and magnesium.
    Paradelis AG; Triantaphyllidis C; Fidani V; Logaras G
    Arzneimittelforschung; 1974 Nov; 24(11):1774-9. PubMed ID: 4480048
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of high concentration of magnesium with ropivacaine, gentamicin, rocuronium, and their combination on neuromuscular blockade.
    Rhee WJ; Lee SY; Lee JH; Choi SR; Lee SC; Lee JH; Lee SI
    Korean J Anesthesiol; 2015 Feb; 68(1):50-61. PubMed ID: 25664156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin-induced hypomagnesemia.
    Finton CK; Bjorkland S; Zaloga GP; Uddin DE; Chernow B
    Am Surg; 1983 Nov; 49(11):576-8. PubMed ID: 6638694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset neonatal hyperkalemia associated with maternal hypermagnesemia: a case report.
    Tanaka K; Mori H; Sakamoto R; Matsumoto S; Mitsubuchi H; Nakamura K; Iwai M
    BMC Pediatr; 2018 Feb; 18(1):55. PubMed ID: 29433462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin extended interval regimen and ototoxicity in neonates.
    El-Barbary MN; Ismail RI; Ibrahim AA
    Int J Pediatr Otorhinolaryngol; 2015 Aug; 79(8):1294-8. PubMed ID: 26071016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of gentamicin nephrotoxicity by magnesium depletion in the rat.
    Rankin LI; Krous H; Fryer AW; Whang R
    Miner Electrolyte Metab; 1984; 10(3):199-203. PubMed ID: 6727806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, effects on renal function, and potentiation of atracurium-induced neuromuscular blockade after administration of a high dose of gentamicin in isoflurane-anesthetized dogs.
    Martinez EA; Mealey KL; Wooldridge AA; Mercer DE; Cooper J; Slater MR; Hartsfield SM
    Am J Vet Res; 1996 Nov; 57(11):1623-6. PubMed ID: 8915441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laxative abuse causing hypermagnesemia, quadriparesis, and neuromuscular junction defect.
    Castelbaum AR; Donofrio PD; Walker FO; Troost BT
    Neurology; 1989 May; 39(5):746-7. PubMed ID: 2710370
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled study of the nephrotoxicity of mezlocillin and gentamicin plus ampicillin in the neonate.
    Adelman RD; Wirth F; Rubio T
    J Pediatr; 1987 Dec; 111(6 Pt 1):888-93. PubMed ID: 3316564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular blockade with magnesium sulfate and nifedipine.
    Snyder SW; Cardwell MS
    Am J Obstet Gynecol; 1989 Jul; 161(1):35-6. PubMed ID: 2750819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular blockade after therapy with magnesium sulfate and amlodipine.
    Wu QA; Ye YQ
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):225. PubMed ID: 20006421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.